Nuvation Bio NUVB Royalty Revenue — Deferred Revenue

Other product segments

Similar metrics at other companies

ANFRoyalty — Contract with Customer, Liability, Current

$34.31M+3.8%

NTRARoyalty — Deferred Revenue

$500K-64.3%

SIGOther Deferred Revenue — Contract with Customer, Liability

$86.5M+6.9%

TNLDeferred other revenue — Contract with Customer, Liability

$11M+175%

CNKOther Deferred Revenues — Deferred Revenue

$272.6M+5.7%

LZBDeferred Revenue

$34.91M+7.1%

Questions, answered.

What is Nuvation Bio's royalty revenue — deferred revenue?

Nuvation Bio (NUVB) reported royalty revenue — deferred revenue of $300K in Q1 2026.

What does royalty revenue — deferred revenue mean?

This metric represents the deferred revenue or performance obligations related to royalty contracts that have been billed or collected but not yet earned. It signifies the company's future obligations to provide services or satisfy contractual requirements under existing licensing or collaboration agreements. Monitoring this balance provides insight into the timing of future revenue recognition and the underlying health of long-term partnership commitments.